HomeProductsBioactive CompoundsImmunology & InflammationCOXKetorolac Tromethamine
Chemical structure of CAS 74103-07-4

Ketorolac Tromethamine

In Stock•Starting at $8 for 1 mg•Purity ≥ 98%
CAS No.74103-07-4
MDL No.N/A
MFC19H24N2O6
MW376.40
InChI KeyBWHLPLXXIDYSNW-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$8In Stock
250 mg98%$10In Stock
1 g98%$18In Stock
5 g98%$51In Stock
25 g98%$171In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.74103-07-4
Product NameKetorolac Tromethamine
Acute ToxicAcute Toxic
IrritantIrritant
Signal Word:Danger
HCode:H301-H315-H319-H335
PCode:P261-P264-P264+P265-P270-P271-P280-P301+P316-P302+P352-P304+P340-P305+P351+P338-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501

Related Articles

Studies related to this compound and its mechanism of action

Melatonin protects against ketorolac induced gastric mucosal toxic injuries through molecular mechanism associated with the modulation of Arylakylamine N-Acetyltransferase (AANAT) activity.

Chemico-biological interactions • Vol. 382 • 2023
PMID: 37348669DOI: 10.1016/j.cbi.2023.110611

An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury.

Archives of toxicology • Vol. 95, Issue 1 • 2021
PMID: 32816093DOI: 10.1007/s00204-020-02882-4

Intravenous ketorolac in the emergency department management of sickle cell pain and predictors of its effectiveness.

Archives of pediatrics & adolescent medicine • Vol. 155, Issue 4 • 2001
PMID: 11296078DOI: 10.1001/archpedi.155.4.496

Postoperative pain management using intravenous patient-controlled analgesia for pediatric patients.

The Journal of craniofacial surgery • Vol. 12, Issue 2 • 2001
PMID: 11314621DOI: 10.1097/00001665-200103000-00007

Documentation

Similar Products